v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 2 $ 40,973 $ 3 $ (48,229) $ (7,251)
Balance (in Shares) at Dec. 31, 2024 22,594,877        
Stock-based compensation 200 200
Issuance of Common Stock from debt offering (net of $158K issuance costs) 377 377
Issuance of Common Stock from debt offering (net of $158K issuance costs) (in Shares) 2,028,846        
Issuance of common stock to pay convertible debt 1,433 1,433
Issuance of common stock to pay convertible debt (in Shares) 610,426        
Sale of common stock (net of $19K issuance costs)   543 543
Sale of common stock (net of $19K issuance costs) (in Shares) 310,925        
Exercise of stock options 158 158
Exercise of stock options (in Shares) 43,047        
Cumulative translation adjustment 17 17
Net income (loss) 2,897 2,897
Balance at Mar. 31, 2025 $ 2 43,684 20 (45,332) (1,626)
Balance (in Shares) at Mar. 31, 2025 25,588,121        
Balance at Dec. 31, 2025 $ 3 50,030 40 (55,800) (5,727)
Balance (in Shares) at Dec. 31, 2025 30,688,895        
Stock-based compensation 183 183
Exercise of stock options 156 156
Exercise of stock options (in Shares) 150,000        
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 50,000        
Cumulative translation adjustment (10) (10)
Pre-funded warrant exercises
Pre-funded warrant exercises (in Shares) 935,000        
Net income (loss) (3,412) (3,412)
Balance at Mar. 31, 2026 $ 3 $ 50,369 $ 30 $ (59,212) $ (8,810)
Balance (in Shares) at Mar. 31, 2026 31,823,895